Blueprint Medicines' GAAP net income for 3M 2021 was $99.714 million, down 10.1% from $110.955 million in the prior year. Revenue tripled to $21.576 million from $6.167 million a year earlier.
Blueprint Medicines' GAAP net income for 3M 2021 was $99.714 million, down 10.1% from $110.955 million in the prior year. Revenue tripled to $21.576 million from $6.167 million a year earlier. 
ir.blueprintmedicines.com
English (US) 